hotspot -WSS

hotspot

author：focus 2025-10-02 08:24:19 - browse：73

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Lawsuit highlights wrinkle for disputes over surprise medical bills

leisure time

WSS

What we owe ALS patients — and why one company fell short

The Bio Revolution is changing business and society

Guardant Health colon cancer test endorsed by FDA advisory panel

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

The biotech scorecard for Q4: 16 stock

Clinicians often fail to acknowledge the pain caused by long Covid

Wikipedia

hotspot

focus

Apple is now the first public company to be valued at $3 trillion

European officials brace for rough respiratory virus season

Alkermes shareholders re

Medicare innovation center doesn’t save money, experts say

Duchenne breakthrough therapy leaves behind pioneering families

Why some fertility treatments produce more boy babies

Malaria cases in Florida and Texas: Here’s what you need to know

Setback for rare diseases as Taysha Gene Therapies pulls back

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hospitals need to get ahead of regulations on climate change

hotspot

U.S. death rates show how politics are affecting public health

Flu, Covid vaccination rates decline, new survey data show

Stroke rates rising, especially in working

New research sheds light on how often breast cancer is overdiagnosed

The stability of $0 premiums in Medicare Advantage

Guardant Health colon cancer test endorsed by FDA advisory panel

leisure time

explore

hotspot

hotspot